Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,798 public trials 1,412 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Active, Not Recruiting

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

NCT05899049

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000) Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital ( Site 6009) Chongqing, Chongqing Municipality, China
  • SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 6003) Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 6036) Guangzhou, Guangdong, China
View all 17 locations
View Trial Details
Active, Not Recruiting

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT06342960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Charite- Universitätsklinikum Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details
Active, Not Recruiting

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT05938725

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Massachusetts Worcester Worcester, Massachusetts, United States
  • Northwell Health Great Neck, New York, United States
View Trial Details
Active, Not Recruiting

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

NCT03589339

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Vasopressin for Septic Shock Pragmatic Trial

NCT06217562

Conditions
Diabetes Insipidus, Endocrine System Diseases, Female Urogenital Diseases, +15 more
Locations
  • Cassia Regional Hospital Burley, Idaho, United States
  • American Fork Hospital American Fork, Utah, United States
  • Cedar City Hospital Cedar City, Utah, United States
  • Layton Hospital Layton, Utah, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details

Related conditions